ID18352A - Komposisi-komposisi farmasi - Google Patents

Komposisi-komposisi farmasi

Info

Publication number
ID18352A
ID18352A IDP971846A ID971846A ID18352A ID 18352 A ID18352 A ID 18352A ID P971846 A IDP971846 A ID P971846A ID 971846 A ID971846 A ID 971846A ID 18352 A ID18352 A ID 18352A
Authority
ID
Indonesia
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IDP971846A
Other languages
English (en)
Inventor
Parikh Bhavnish Vinod
Timko Robert Joseph
Addicks William Joseph
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10794541&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID18352(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ID18352A publication Critical patent/ID18352A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
IDP971846A 1996-05-31 1997-05-30 Komposisi-komposisi farmasi ID18352A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9611328.7A GB9611328D0 (en) 1996-05-31 1996-05-31 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ID18352A true ID18352A (id) 1998-04-02

Family

ID=10794541

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971846A ID18352A (id) 1996-05-31 1997-05-30 Komposisi-komposisi farmasi

Country Status (31)

Country Link
EP (1) EP0907364B1 (id)
JP (5) JP2000511170A (id)
CN (3) CN1142780C (id)
AR (1) AR003662A1 (id)
AT (1) ATE222105T1 (id)
AU (1) AU727219B2 (id)
BR (1) BR9709271A (id)
CA (1) CA2251944C (id)
CZ (1) CZ293760B6 (id)
DE (1) DE69714739T2 (id)
DK (1) DK0907364T3 (id)
EG (1) EG24118A (id)
ES (1) ES2182079T3 (id)
GB (2) GB9611328D0 (id)
HR (1) HRP970299B1 (id)
HU (1) HU225152B1 (id)
ID (1) ID18352A (id)
IL (1) IL127222A (id)
MY (1) MY120120A (id)
NO (1) NO327801B1 (id)
NZ (1) NZ332198A (id)
PL (1) PL189887B1 (id)
PT (1) PT907364E (id)
RU (1) RU2201754C2 (id)
SI (1) SI0907364T1 (id)
SK (1) SK284131B6 (id)
TR (1) TR199802483T2 (id)
TW (1) TW550076B (id)
UA (1) UA50772C2 (id)
WO (1) WO1997045124A1 (id)
ZA (1) ZA974735B (id)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
SE0003126D0 (sv) * 2000-09-05 2000-09-05 Astrazeneca Ab Method of treatment
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
SE0102855D0 (sv) * 2001-08-27 2001-08-27 Astrazeneca Ab Method of treatment
EP1448169A1 (en) * 2001-11-07 2004-08-25 Fujisawa Pharmaceutical Co., Ltd. Method for improving dissolution of poorly dispersible medicaments
TW200735878A (en) * 2005-11-18 2007-10-01 Astrazeneca Ab Pharmaceutical compositions
US20100178333A1 (en) 2006-01-25 2010-07-15 Astron Research Limited Sustained release dosage form of phenothiazine derivatives containing channelizer
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
GB0618879D0 (en) * 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
EP1958617B1 (en) 2007-02-14 2010-09-08 Laboratorios Lesvi, S.L. Pharmaceutical compositions containing quetiapine fumarate
EP2131817A2 (en) 2007-03-09 2009-12-16 Synthon B.V. Pharmaceutical composition of quetiapine fumarate
US20080287418A1 (en) * 2007-05-16 2008-11-20 Astrazeneca Ab Extended Release Compositions and Methods for Their Manufacture
ES2402342T3 (es) * 2008-08-01 2013-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Composición de quetiapina
EP2153834A3 (en) 2008-08-07 2010-02-24 Farmaprojects, S.A. Extended release pharmaceutical compositions comprising quetiapine salts
DE102008046650A1 (de) 2008-09-10 2010-03-11 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Quetiapin enthaltende Retardtablette
WO2010082220A2 (en) * 2009-01-05 2010-07-22 Torrent Pharmaceuticals Limited Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
WO2010089259A2 (en) 2009-02-04 2010-08-12 Woerwag R&D Gmbh Sustained release composition containing quetiapine
EP2233130A1 (en) * 2009-03-23 2010-09-29 Genepharm (Europe) Trading Limited A sustained release oral composition of an antipsychotic agent
AR076907A1 (es) * 2009-05-13 2011-07-20 Wyeth Llc Composiciones con liberacion rapida de farmaco
WO2011132008A2 (en) 2010-04-22 2011-10-27 EGIS Gyűgyszergyár Nyilvánosan Múködő Részvény társaság Controlled release pharmaceutical composition
WO2011154118A1 (en) 2010-06-07 2011-12-15 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Quetiapine prolonged-release tablets
DE102010033527A1 (de) 2010-08-05 2012-02-09 Acino Pharma Ag Quetiapin-Tabletten
TR201008261A1 (tr) 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
CN102218042A (zh) * 2011-05-26 2011-10-19 青岛黄海制药有限责任公司 富马酸喹硫平组合物的缓释片剂及其制备方法
DE102011115690A1 (de) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapin enthaltende Formulierungen
CN102406606B (zh) * 2011-11-29 2013-01-23 海南美大制药有限公司 富马酸喹硫平脂质体固体制剂
WO2014037022A1 (en) 2012-09-10 2014-03-13 Pharmathen S.A. Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
EP2848244A1 (en) 2013-09-16 2015-03-18 Yildiz Özsoy Erginer Extended release tablet formulations of quetiapine
AU2016278846B2 (en) * 2015-06-19 2021-08-05 Biotie Therapies, Inc. Controlled-release tozadenant formulations
CN106187873B (zh) * 2016-07-25 2019-11-05 宜春学院 一种芳胺基烷基氧类化合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
EP0266707B1 (en) * 1986-11-03 1992-01-22 Schering Corporation Sustained release labetalol tablet
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound
US4983398A (en) * 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
SE9003902D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Solid dosage forms of a drug
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
JP3116970B2 (ja) * 1991-06-12 2000-12-11 三菱東京製薬株式会社 ペミロラストカリウムの徐放性製剤
IT1256393B (it) * 1992-11-17 1995-12-04 Inverni Della Beffa Spa Forme matriciali multistrato per il rilascio controllato di principi attivi
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
CA2190188A1 (en) * 1994-05-13 1995-11-23 Prasad S. Adusumilli Method and composition for increasing calcium uptake

Also Published As

Publication number Publication date
ES2182079T3 (es) 2003-03-01
DE69714739T2 (de) 2003-05-15
EP0907364A1 (en) 1999-04-14
CN1142780C (zh) 2004-03-24
HUP9902194A3 (en) 2000-03-28
IL127222A0 (en) 2000-06-01
GB9611328D0 (en) 1996-08-07
CZ388098A3 (cs) 1999-02-17
MY120120A (en) 2005-09-30
NO985539D0 (no) 1998-11-27
AR003662A1 (es) 1998-09-09
IL127222A (en) 2001-03-19
PL189887B1 (pl) 2005-10-31
ZA974735B (en) 1997-12-01
DE69714739D1 (de) 2002-09-19
CZ293760B6 (cs) 2004-07-14
HUP9902194A2 (hu) 2000-02-28
JP5888549B2 (ja) 2016-03-22
JP2000511170A (ja) 2000-08-29
SK163998A3 (en) 1999-05-07
CA2251944C (en) 2007-04-10
HRP970299B1 (en) 2001-12-31
JP2014167026A (ja) 2014-09-11
SK284131B6 (sk) 2004-09-08
TW550076B (en) 2003-09-01
EP0907364B1 (en) 2002-08-14
CA2251944A1 (en) 1997-12-04
BR9709271A (pt) 1999-08-10
PL330223A1 (en) 1999-05-10
AU727219B2 (en) 2000-12-07
NO327801B1 (no) 2009-09-28
NO985539L (no) 1998-11-27
CN1219879A (zh) 1999-06-16
DK0907364T3 (da) 2002-11-11
GB9709761D0 (en) 1997-07-09
HRP970299A2 (en) 1998-04-30
EG24118A (en) 2008-07-06
TR199802483T2 (xx) 1999-02-22
WO1997045124A1 (en) 1997-12-04
JP2012031206A (ja) 2012-02-16
JP2007119495A (ja) 2007-05-17
CN101006985A (zh) 2007-08-01
AU2967597A (en) 1998-01-05
HU225152B1 (en) 2006-07-28
RU2201754C2 (ru) 2003-04-10
SI0907364T1 (en) 2003-02-28
UA50772C2 (uk) 2002-11-15
CN1511532A (zh) 2004-07-14
JP2006152006A (ja) 2006-06-15
ATE222105T1 (de) 2002-08-15
NZ332198A (en) 2000-05-26
PT907364E (pt) 2002-12-31

Similar Documents

Publication Publication Date Title
ID18352A (id) Komposisi-komposisi farmasi
IS4706A (is) Lyfjasamsetningar
DK0938345T3 (da) Vandbaseret farmaceutisk sammensætning
EA199900373A3 (ru) Фармацевтические композиции
ATE209959T1 (de) Mikroverkapselte zusammensetzungen
ATE293672T1 (de) Farbschonende zusammensetzungen
DE69719442D1 (de) Frisierschaum-Zusammensetzungen
ID16781A (id) Formulasi-formulasi farmasi
EE9900260A (et) Ravimkompositsioonid külmkuivatamiseks
IS5184A (is) Lyfjasamsetningar
BR9507768A (pt) Composição farmacêutica
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
PT941100E (pt) Composicoes farmaceuticas
EE200000330A (et) Farmatseutilised kompositsioonid
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
IS5569A (is) Lyfjasamsetningar
ITMI962628A0 (it) Composizione farmaceutica
FI962738A (fi) Farmaseuttiset koostumukset
NO994436D0 (no) Farmasöytiske sammensetninger
SE9604299D0 (sv) Pharmaceutical composition
ID17133A (id) Komposisi farmasi
SE9601854D0 (sv) Farmaceutisk komposition
ID21960A (id) Komposisi-komposisi hidrofluorokarbon
BR1100755A (pt) composição farmacêutica
SE9402437D0 (sv) Pharmaceutical composition